EACTS - CytoSorbents Symposium 2

Role of CytoSorb hemoadsorption therapy in endocarditis patients
Chair: Carlos Mestres, Zurich/Switzerland

• Intraoperative use – First results from the REMOVE trial
  Torsten Doenst, Jena/Germany
• Intraoperative and postoperative use – Which patients benefit most?
  Daniel Wendt, Essen/Germany
• Can hemoadsorption reduce the amount of postoperative vasoactive drugs?
  Anna Holmén, Gothenburg/Sweden
• We need an individualized approach – Results of a large retrospective study
  Jurij Kalisnik, Nuernberg/Germany